Search Results 811-820 of 17676 for Prednisone

1. Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab - Mayo Clinic

   Must be on a stable dose of oral prednisolone or prednisone of ≥7.5 mg/day (but not \>50mg/day) for at least 4 weeks prior to randomization. 5. If ...

2. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

   Steroids (i.e., prednisone/budesonide/budesonide MMX); Immunosuppressant (i.e., methotrexate/azathioprine/6-mercaptopurine); Other immunosuppressant (i.e. ...

3. Mayo Clinic

   ... . VID-20464038. Home; Shaylas Story. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in impact thanks to a ...

4. Phase III Study of DCVAC Added to Standard Chemotherapy for Men with Metastatic Castration Resistant Prostate Cancer - Mayo Clinic

   Subjects who are not indicated for chemotherapy treatment with first line Standard of Care chemotherapy (docetaxel and prednisone); Systemic corticosteroids ...

5. Etodolac (oral route) - Side effects & dosage - Mayo Clinic

   Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain, and helps to relieve symptoms of arthritis (eg, osteoarthritis ...

6. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   EXCEPTION: low doses of steroids (< 10 mg of prednisone or equivalent dose of other steroid) used for treatment of non-hematologic medical conditions ...

7. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

   Received two or more doses of > 60 mg of prednisone or equivalent in the 7 days prior to screening. Received small molecule tyrosine kinase inhibitors ...

8. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

   Participation eligibility · treatment with corticosteroids at a dose that exceeds the prednisone equivalent of >40 mg; · treatment with immunomodulatory agents ( ...

9. Mayo Clinic

   Double your impact on cancer! ... Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge. Give Now.

10. A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors - Mayo Clinic

    Note: Subjects in any condition requiring systemic treatment with corticosteroids (prednisone > 10 mg/day or equivalent of the similar drug) or other ...